Skip to content

PTC Therapeutics PTCT Other Financing

Other Financing at other companies

Biogen logo
BiogenBIIB
$11.3M+769%
Tenet Healthcare logo
Tenet HealthcareTHC
-$77M-1,000%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's other financing?
PTC Therapeutics (PTCT) reported other financing of $6.34M in Q1 2025.
How has PTC Therapeutics's other financing changed year-over-year?
PTC Therapeutics's other financing increased by 39.4% year-over-year, from $4.55M to $6.34M.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.